Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Trial of Tauroursodeoxycholic Acid Supplementation in Patients with Progressive MS

Author:Harrison, Kimystian   Ladakis, Dimitrios   Hwang, Soonmyung   Sotirchos, Elias   Calabresi, Peter   Bhargava, Pavan   

Session Name:S16: MS Clinical Trials and Therapeutics  

Topic:MS and Inflammatory Disease  

Program Number:S16.007  

Author Institution:Johns Hopkins University, School of Medicine, Baltimore, MD  

Pemigatinib For Previously Treated Central Nervous System Tumors With Activating FGFR Mutations or Translocations: Results From FIGHT-207

Author:Spanggaard, Iben   Matrana, Marc   Rocha-Lima, Caio   Mahipal, Amit   Vieito, Maria   Hervieu, Alice   Ahn, Myung-Ju   Goyal, Lipika   Rodon Ahnert, Jordi   Veronese, Luisa   Oliveira, Natalia   Li, Xin   Schaffer, Michael   Kesari, Santosh   

Session Name:S17: Innovations in Neuro-oncology  

Topic:Neuro-oncology  

Program Number:S17.004  

Author Institution:Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark  Ochsner Cancer Institute, Ochsner Clinic Foundation , New Orleans, LA  Wake Forest University School of Medicine, Winston-Salem, NC  Mayo Clinic  Seidman Cancer Center/Case Western Reserve University, Rochester, MN  Vall d'Hebron University Hospital, Barcelona, Spain  Centre Georges-François Leclerc, Dijon, France  Samsung Medical Center, Seoul, Korea, Republic of  Mass General Cancer Center, Harvard Medical School, Boston, MA  The University of Texas MD Anderson Cancer Center, Houston, TX  Incyte International Biosciences Sàrl, Morges, Switzerland  Incyte Corporation, Wilmington, DE  Providence Southern California Research Clinical Institute, Saint John’s Cancer Institute, Pacific Neuroscience Institute, Los Angeles, CA  

Machine Learning Models to Predict Severity and Mortality of COVID-19 Using Neurological Symptoms

Author:Salehi, Mona   Garakani, Amir   Amanat, Man   

Session Name:S21: Acute and Post-Acute Sequelae of COVID-19  

Topic:Infectious Disease  

Program Number:S21.002  

Author Institution:Johns Hopkins Medical School, Baltimore, MD  Yale Medicine, New Haven, CT  Kennedy Krieger Institute, Baltimore, MD  

Latinx with multiple sclerosis have greater disability and loss of deep and cortical gray matter

Author:Ontaneda, Daniel   McGinley, Marisa   Harvey, Tucker   Fitzgerald, Kathryn   Mowry, Ellen   Cohen, Jeffrey   Briggs, Farren   

Session Name:S31: MS Clinical Decision Making and Special Populations  

Topic:MS and Inflammatory Disease  

Program Number:S31.003  

Author Institution:Cleveland Clinic, Cleveland, OH  Johns Hopkins University, Baltimore, MD  Case Western Reserve University, Cleveland, OH  

Spinraza in Adults with Spinal Muscular Atrophy (SAS) – 14 month results

Author:Zaidman, Craig   Proud, Crystal   Thonhoff, Jason   Rad, Nassim   Ho, Doreen   Chu, MaryLynn   Ladha, Shafeeq   Crawford, Thomas   Nayar, Shakti   Genge, Angela   Frey, Margaret   Heatwole, Chad   Lew, Daphne   

Session Name:S33: ALS and Motor Neuron Diseases  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S33.010  

Author Institution:Washington University in St Louis, St. Louis, MO  CSG Child & Adolescent Neurology, Norfolk, VA  Houston Methodist Hospital, Houston, TX  University of Washington , Seattle, WA  Massachusetts General Hospital, Boston, MA  NYU-Langone Othopedic Hospital, New York, NY  Barrow Neurological Institute, Phoenix, AZ  Johns Hopkins Hospital, Baltimore, MD  Georgetown, Washington, DC  Mcgill University, Montreal, QC, Canada  Memorial Healthcare , Williamston, MI  University of Rochester Medical Center, Rochester, NY  Washington University School of Medicine, Saint Louis, MO